Biotech News
Immuneering to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
ir.immuneering.com2026-05-06 15:04 EST
NEW YORK, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a late-stage clinical oncology company focused on keeping cancer patients alive and helping them thrive, today announced that management will present at the Oppenheimer 36th Annual Healthcare Life Sciences